Alfredo Castelli

Novel Approaches for Preventing or Limiting Events (Naples) II Trial

Carlo Briguori, Gabriella Visconti, Amelia Focaccio et al. · Journal of the American College of Cardiology · 2009 · 240 citations

Preventive Medicine, Clinical Trial Management, Clinical Trials +7

N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity

Carlo Briguori, Antonio Colombo, Flavio Airoldi et al. · Journal of the American College of Cardiology · 2004 · 98 citations

Contrast Agent-associated Nephrotoxicity, Molecular Pharmacology, Medicine +5

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral Anticoagulation

Renata Rogacka, Alaide Chieffo, Iassen Michev et al. · JACC: Cardiovascular Interventions · 2008 · 95 citations

Thrombosis, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy +11

Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease

Flavio Airoldi, Antonio Colombo, Davide Tavano et al. · The American Journal of Cardiology · 2004 · 88 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Diamond-like Carbon-coated Stents +9

Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

Cosmo Godino, Loredana Mendolicchio, Filippo Figini et al. · Thrombosis Journal · 2009 · 52 citations · Full text